Urine peptidome analysis in cardiorenal syndrome reflects molecular processes

Eleni Petra1,2, Tianlin He1,3, Vasiliki Lygirou2

  • 1Institute for Molecular Cardiovascular Research, RWTH Aachen University Hospital, Pauwelsstraße 30, 52074, Aachen, Germany.

Scientific Reports
|August 11, 2021
PubMed

Insights

This study reveals distinct urinary peptide profiles in cardiorenal syndrome (CRS) patients, identifying specific peptides and proteases linked to heart and kidney dysfunction. These findings offer new insights into CRS pathophysiology.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Nephrology

Background:

  • Cardiorenal syndrome (CRS) involves complex heart-kidney dysfunction.
  • Understanding the molecular underpinnings of CRS is crucial for diagnosis and treatment.
  • The urinary peptidome offers a window into systemic physiological changes.

Purpose of the Study:

  • To investigate molecular differences in the urinary peptidome between CRS patients and controls.
  • To identify specific peptides associated with CRS pathophysiology.
  • To explore the role of proteases in generating CRS-associated peptides.

Main Methods:

  • Comparative analysis of urinary peptidomes from CRS patients (n=353) and matched controls (n=356).
  • Statistical analysis using the Mann-Whitney test with correction for multiple testing.
  • Protease prediction using the Proteasix tool and pathway enrichment analysis.

Main Results:

  • 559 differentially excreted urinary peptides were identified in CRS patients.
  • 193 peptides were unique to CRS compared to heart failure and chronic kidney disease profiles.
  • 18 proteases were predicted to be involved, with MMP13, MMP9, and MMP2 responsible for 44% of cleavage events.
  • ECM-related pathways, fibrosis, and inflammation were significantly represented.

Conclusions:

  • The study characterizes unique urinary peptide changes in CRS patients.
  • Key proteases, including MMPs, are implicated in CRS-associated peptide generation.
  • These findings provide a basis for further validation and potential diagnostic markers for CRS.

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
40
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
339
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
272
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
444
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
322
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
4.1K